nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbamazepine—RALBP1—Vincristine—hematologic cancer	0.0615	0.0998	CbGbCtD
Carbamazepine—ABCB1—hematologic cancer	0.0596	1	CbGaD
Carbamazepine—RALBP1—Doxorubicin—hematologic cancer	0.0384	0.0624	CbGbCtD
Carbamazepine—ABCC2—Daunorubicin—hematologic cancer	0.0154	0.025	CbGbCtD
Carbamazepine—UGT2B7—Epirubicin—hematologic cancer	0.0144	0.0234	CbGbCtD
Carbamazepine—CYP1A2—Anagrelide—hematologic cancer	0.0141	0.023	CbGbCtD
Carbamazepine—CYP2B6—Thiotepa—hematologic cancer	0.0139	0.0225	CbGbCtD
Carbamazepine—CYP2C9—Bexarotene—hematologic cancer	0.00883	0.0143	CbGbCtD
Carbamazepine—ABCB1—Lenalidomide—hematologic cancer	0.00857	0.0139	CbGbCtD
Carbamazepine—CYP3A7—Ifosfamide—hematologic cancer	0.00825	0.0134	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00825	0.0134	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.00788	0.0128	CbGbCtD
Carbamazepine—CYP3A7—Imatinib—hematologic cancer	0.00788	0.0128	CbGbCtD
Carbamazepine—CYP2B6—Ifosfamide—hematologic cancer	0.00786	0.0128	CbGbCtD
Carbamazepine—CYP2C8—Bortezomib—hematologic cancer	0.00776	0.0126	CbGbCtD
Carbamazepine—CYP3A5—Daunorubicin—hematologic cancer	0.00772	0.0125	CbGbCtD
Carbamazepine—CYP1A2—Carmustine—hematologic cancer	0.00743	0.0121	CbGbCtD
Carbamazepine—ABCC2—Irinotecan—hematologic cancer	0.00738	0.012	CbGbCtD
Carbamazepine—CYP2C9—Idarubicin—hematologic cancer	0.00732	0.0119	CbGbCtD
Carbamazepine—CYP3A5—Thalidomide—hematologic cancer	0.00703	0.0114	CbGbCtD
Carbamazepine—CYP2B6—Nilotinib—hematologic cancer	0.00682	0.0111	CbGbCtD
Carbamazepine—CYP3A5—Teniposide—hematologic cancer	0.00671	0.0109	CbGbCtD
Carbamazepine—ABCC2—Vinblastine—hematologic cancer	0.00656	0.0106	CbGbCtD
Carbamazepine—CYP2C19—Bortezomib—hematologic cancer	0.00651	0.0106	CbGbCtD
Carbamazepine—ABCC2—Vincristine—hematologic cancer	0.00645	0.0105	CbGbCtD
Carbamazepine—CYP1A2—Methoxsalen—hematologic cancer	0.00632	0.0103	CbGbCtD
Carbamazepine—CYP3A5—Ifosfamide—hematologic cancer	0.00619	0.0101	CbGbCtD
Carbamazepine—ABCC2—Cisplatin—hematologic cancer	0.00601	0.00976	CbGbCtD
Carbamazepine—CYP1A2—Bortezomib—hematologic cancer	0.00601	0.00976	CbGbCtD
Carbamazepine—CYP2C8—Ifosfamide—hematologic cancer	0.00595	0.00967	CbGbCtD
Carbamazepine—CYP3A5—Imatinib—hematologic cancer	0.00591	0.0096	CbGbCtD
Carbamazepine—ABCC2—Etoposide—hematologic cancer	0.00591	0.00959	CbGbCtD
Carbamazepine—CYP1A2—Daunorubicin—hematologic cancer	0.00575	0.00933	CbGbCtD
Carbamazepine—CYP2C19—Thalidomide—hematologic cancer	0.00567	0.00921	CbGbCtD
Carbamazepine—CYP1A2—Alitretinoin—hematologic cancer	0.00563	0.00914	CbGbCtD
Carbamazepine—CYP2C9—Bortezomib—hematologic cancer	0.00541	0.00879	CbGbCtD
Carbamazepine—CYP2C19—Teniposide—hematologic cancer	0.00541	0.00879	CbGbCtD
Carbamazepine—CYP1A2—Thalidomide—hematologic cancer	0.00523	0.0085	CbGbCtD
Carbamazepine—CYP2C8—Nilotinib—hematologic cancer	0.00517	0.00839	CbGbCtD
Carbamazepine—CYP3A4—Bexarotene—hematologic cancer	0.00514	0.00834	CbGbCtD
Carbamazepine—ABCB1—Daunorubicin—hematologic cancer	0.00503	0.00816	CbGbCtD
Carbamazepine—CYP2C19—Ifosfamide—hematologic cancer	0.00499	0.00811	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00492	0.008	CbGbCtD
Carbamazepine—CYP3A7—Irinotecan—hematologic cancer	0.00492	0.008	CbGbCtD
Carbamazepine—ABCB1—Alitretinoin—hematologic cancer	0.00492	0.00799	CbGbCtD
Carbamazepine—ABCC2—Dexamethasone—hematologic cancer	0.00486	0.00789	CbGbCtD
Carbamazepine—CYP3A4—Lomustine—hematologic cancer	0.00477	0.00775	CbGbCtD
Carbamazepine—CYP3A4—Busulfan—hematologic cancer	0.00477	0.00775	CbGbCtD
Carbamazepine—CYP2C19—Imatinib—hematologic cancer	0.00477	0.00775	CbGbCtD
Carbamazepine—CYP3A5—Dasatinib—hematologic cancer	0.00475	0.00771	CbGbCtD
Carbamazepine—CYP2C9—Thalidomide—hematologic cancer	0.00472	0.00766	CbGbCtD
Carbamazepine—CYP2B6—Irinotecan—hematologic cancer	0.00469	0.00761	CbGbCtD
Carbamazepine—CYP1A2—Dacarbazine—hematologic cancer	0.0045	0.00731	CbGbCtD
Carbamazepine—CYP2C9—Teniposide—hematologic cancer	0.0045	0.00731	CbGbCtD
Carbamazepine—CYP1A2—Imatinib—hematologic cancer	0.0044	0.00715	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0043	0.00699	CbGbCtD
Carbamazepine—CYP3A7—Vincristine—hematologic cancer	0.0043	0.00699	CbGbCtD
Carbamazepine—CYP3A4—Thiotepa—hematologic cancer	0.00426	0.00691	CbGbCtD
Carbamazepine—CYP2C9—Ifosfamide—hematologic cancer	0.00415	0.00674	CbGbCtD
Carbamazepine—ABCC2—Doxorubicin—hematologic cancer	0.00403	0.00654	CbGbCtD
Carbamazepine—CYP2C9—Imatinib—hematologic cancer	0.00397	0.00644	CbGbCtD
Carbamazepine—ABCC2—Methotrexate—hematologic cancer	0.0039	0.00634	CbGbCtD
Carbamazepine—ABCB1—Imatinib—hematologic cancer	0.00385	0.00625	CbGbCtD
Carbamazepine—CYP2B6—Cisplatin—hematologic cancer	0.00382	0.00621	CbGbCtD
Carbamazepine—CYP3A5—Irinotecan—hematologic cancer	0.00369	0.006	CbGbCtD
Carbamazepine—CYP2C9—Nilotinib—hematologic cancer	0.0036	0.00585	CbGbCtD
Carbamazepine—CYP1A2—Dasatinib—hematologic cancer	0.00354	0.00574	CbGbCtD
Carbamazepine—ABCB1—Nilotinib—hematologic cancer	0.0035	0.00568	CbGbCtD
Carbamazepine—ABCB1—Vinorelbine—hematologic cancer	0.00347	0.00563	CbGbCtD
Carbamazepine—CYP3A4—Methoxsalen—hematologic cancer	0.00331	0.00537	CbGbCtD
Carbamazepine—CYP3A7—Dexamethasone—hematologic cancer	0.00324	0.00527	CbGbCtD
Carbamazepine—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00324	0.00527	CbGbCtD
Carbamazepine—CYP3A5—Vincristine—hematologic cancer	0.00323	0.00524	CbGbCtD
Carbamazepine—CYP3A4—Bortezomib—hematologic cancer	0.00315	0.00511	CbGbCtD
Carbamazepine—CYP2C19—Prednisone—hematologic cancer	0.00314	0.0051	CbGbCtD
Carbamazepine—ABCB1—Dasatinib—hematologic cancer	0.00309	0.00502	CbGbCtD
Carbamazepine—CYP2B6—Dexamethasone—hematologic cancer	0.00309	0.00501	CbGbCtD
Carbamazepine—ABCB1—Mitoxantrone—hematologic cancer	0.00305	0.00496	CbGbCtD
Carbamazepine—CYP3A4—Daunorubicin—hematologic cancer	0.00301	0.00489	CbGbCtD
Carbamazepine—CYP3A5—Etoposide—hematologic cancer	0.00296	0.0048	CbGbCtD
Carbamazepine—CYP2C8—Etoposide—hematologic cancer	0.00285	0.00462	CbGbCtD
Carbamazepine—ABCB1—Betamethasone—hematologic cancer	0.00272	0.00442	CbGbCtD
Carbamazepine—ABCB1—Gemcitabine—hematologic cancer	0.0027	0.00438	CbGbCtD
Carbamazepine—ABCB1—Prednisolone—hematologic cancer	0.00269	0.00436	CbGbCtD
Carbamazepine—CYP3A4—Cytarabine—hematologic cancer	0.00266	0.00431	CbGbCtD
Carbamazepine—CYP3A4—Teniposide—hematologic cancer	0.00262	0.00425	CbGbCtD
Carbamazepine—CYP2B6—Doxorubicin—hematologic cancer	0.00256	0.00416	CbGbCtD
Carbamazepine—ABCB1—Prednisone—hematologic cancer	0.00254	0.00412	CbGbCtD
Carbamazepine—CYP3A5—Dexamethasone—hematologic cancer	0.00243	0.00395	CbGbCtD
Carbamazepine—CYP3A4—Ifosfamide—hematologic cancer	0.00241	0.00392	CbGbCtD
Carbamazepine—ABCB1—Irinotecan—hematologic cancer	0.0024	0.0039	CbGbCtD
Carbamazepine—CYP2C8—Dexamethasone—hematologic cancer	0.00234	0.0038	CbGbCtD
Carbamazepine—CYP3A4—Imatinib—hematologic cancer	0.00231	0.00374	CbGbCtD
Carbamazepine—CYP1A2—Etoposide—hematologic cancer	0.0022	0.00358	CbGbCtD
Carbamazepine—CYP3A4—Ruxolitinib—hematologic cancer	0.00217	0.00353	CbGbCtD
Carbamazepine—ABCB1—Vinblastine—hematologic cancer	0.00214	0.00347	CbGbCtD
Carbamazepine—ABCB1—Vincristine—hematologic cancer	0.0021	0.00341	CbGbCtD
Carbamazepine—CYP3A4—Nilotinib—hematologic cancer	0.0021	0.0034	CbGbCtD
Carbamazepine—CYP3A4—Vinorelbine—hematologic cancer	0.00208	0.00337	CbGbCtD
Carbamazepine—CYP2C9—Cisplatin—hematologic cancer	0.00202	0.00328	CbGbCtD
Carbamazepine—CYP2C19—Dexamethasone—hematologic cancer	0.00196	0.00319	CbGbCtD
Carbamazepine—ABCB1—Cisplatin—hematologic cancer	0.00196	0.00318	CbGbCtD
Carbamazepine—ABCB1—Etoposide—hematologic cancer	0.00193	0.00313	CbGbCtD
Carbamazepine—CYP3A4—Triamcinolone—hematologic cancer	0.0019	0.00309	CbGbCtD
Carbamazepine—CYP3A4—Dasatinib—hematologic cancer	0.00185	0.00301	CbGbCtD
Carbamazepine—CYP3A4—Mitoxantrone—hematologic cancer	0.00183	0.00297	CbGbCtD
Carbamazepine—CYP2C9—Dexamethasone—hematologic cancer	0.00163	0.00265	CbGbCtD
Carbamazepine—CYP3A4—Betamethasone—hematologic cancer	0.00163	0.00265	CbGbCtD
Carbamazepine—CYP3A4—Prednisolone—hematologic cancer	0.00161	0.00261	CbGbCtD
Carbamazepine—ABCB1—Dexamethasone—hematologic cancer	0.00158	0.00257	CbGbCtD
Carbamazepine—CYP3A4—Prednisone—hematologic cancer	0.00152	0.00247	CbGbCtD
Carbamazepine—CYP3A4—Irinotecan—hematologic cancer	0.00144	0.00234	CbGbCtD
Carbamazepine—RALBP1—hematopoietic system—hematologic cancer	0.00133	0.0698	CbGeAlD
Carbamazepine—ABCB1—Doxorubicin—hematologic cancer	0.00131	0.00213	CbGbCtD
Carbamazepine—CYP3A4—Vinblastine—hematologic cancer	0.00128	0.00208	CbGbCtD
Carbamazepine—ABCB1—Methotrexate—hematologic cancer	0.00127	0.00207	CbGbCtD
Carbamazepine—CYP3A4—Vincristine—hematologic cancer	0.00126	0.00204	CbGbCtD
Carbamazepine—CYP3A4—Etoposide—hematologic cancer	0.00115	0.00187	CbGbCtD
Carbamazepine—CYP3A4—Dexamethasone—hematologic cancer	0.000949	0.00154	CbGbCtD
Carbamazepine—RALBP1—blood—hematologic cancer	0.000884	0.0462	CbGeAlD
Carbamazepine—RALBP1—bone marrow—hematologic cancer	0.000856	0.0447	CbGeAlD
Carbamazepine—SCN9A—lung—hematologic cancer	0.000801	0.0419	CbGeAlD
Carbamazepine—CYP3A4—Doxorubicin—hematologic cancer	0.000787	0.00128	CbGbCtD
Carbamazepine—RALBP1—lung—hematologic cancer	0.000775	0.0405	CbGeAlD
Carbamazepine—SCN9A—testis—hematologic cancer	0.000756	0.0395	CbGeAlD
Carbamazepine—RALBP1—testis—hematologic cancer	0.000731	0.0383	CbGeAlD
Carbamazepine—UGT2B7—testis—hematologic cancer	0.000731	0.0383	CbGeAlD
Carbamazepine—SCN4A—testis—hematologic cancer	0.000674	0.0353	CbGeAlD
Carbamazepine—SCN5A—blood—hematologic cancer	0.000632	0.0331	CbGeAlD
Carbamazepine—CYP2C19—hematopoietic system—hematologic cancer	0.000615	0.0322	CbGeAlD
Carbamazepine—SCN9A—lymph node—hematologic cancer	0.000548	0.0287	CbGeAlD
Carbamazepine—CYP2C8—hematopoietic system—hematologic cancer	0.000537	0.0281	CbGeAlD
Carbamazepine—RALBP1—lymph node—hematologic cancer	0.00053	0.0277	CbGeAlD
Carbamazepine—CYP1A2—hematopoietic system—hematologic cancer	0.000502	0.0263	CbGeAlD
Carbamazepine—CYP3A5—hematopoietic system—hematologic cancer	0.000485	0.0253	CbGeAlD
Carbamazepine—CYP2B6—hematopoietic system—hematologic cancer	0.000482	0.0252	CbGeAlD
Carbamazepine—CYP2C9—hematopoietic system—hematologic cancer	0.000477	0.0249	CbGeAlD
Carbamazepine—ABCC2—blood—hematologic cancer	0.000474	0.0248	CbGeAlD
Carbamazepine—CYP2C19—blood—hematologic cancer	0.000408	0.0213	CbGeAlD
Carbamazepine—ABCC2—testis—hematologic cancer	0.000392	0.0205	CbGeAlD
Carbamazepine—CYP2B6—gonad—hematologic cancer	0.000366	0.0192	CbGeAlD
Carbamazepine—CYP3A4—hematopoietic system—hematologic cancer	0.000364	0.019	CbGeAlD
Carbamazepine—CYP2C8—blood—hematologic cancer	0.000356	0.0186	CbGeAlD
Carbamazepine—CYP1A2—blood—hematologic cancer	0.000333	0.0174	CbGeAlD
Carbamazepine—CYP3A5—blood—hematologic cancer	0.000321	0.0168	CbGeAlD
Carbamazepine—CYP2B6—blood—hematologic cancer	0.000319	0.0167	CbGeAlD
Carbamazepine—CYP2C9—blood—hematologic cancer	0.000316	0.0165	CbGeAlD
Carbamazepine—CYP2C8—testis—hematologic cancer	0.000294	0.0154	CbGeAlD
Carbamazepine—CYP1A2—lung—hematologic cancer	0.000292	0.0153	CbGeAlD
Carbamazepine—ABCC2—lymph node—hematologic cancer	0.000284	0.0149	CbGeAlD
Carbamazepine—CYP3A5—lung—hematologic cancer	0.000281	0.0147	CbGeAlD
Carbamazepine—CYP2B6—lung—hematologic cancer	0.00028	0.0146	CbGeAlD
Carbamazepine—CYP2B6—testis—hematologic cancer	0.000264	0.0138	CbGeAlD
Carbamazepine—ABCB1—hematopoietic system—hematologic cancer	0.000257	0.0135	CbGeAlD
Carbamazepine—CYP3A4—blood—hematologic cancer	0.000241	0.0126	CbGeAlD
Carbamazepine—ABCB1—gonad—hematologic cancer	0.000196	0.0102	CbGeAlD
Carbamazepine—ABCB1—blood—hematologic cancer	0.000171	0.00892	CbGeAlD
Carbamazepine—ABCB1—bone marrow—hematologic cancer	0.000165	0.00863	CbGeAlD
Carbamazepine—ABCB1—lung—hematologic cancer	0.00015	0.00782	CbGeAlD
Carbamazepine—ABCB1—testis—hematologic cancer	0.000141	0.00738	CbGeAlD
Carbamazepine—ABCB1—lymph node—hematologic cancer	0.000102	0.00535	CbGeAlD
Carbamazepine—Magnesium salicylate—ALB—hematologic cancer	8.85e-05	0.154	CrCbGaD
Carbamazepine—Desipramine—SLC22A1—hematologic cancer	7.91e-05	0.137	CrCbGaD
Carbamazepine—Protriptyline—ABCB1—hematologic cancer	7.29e-05	0.127	CrCbGaD
Carbamazepine—Imipramine—SLC22A1—hematologic cancer	6.71e-05	0.117	CrCbGaD
Carbamazepine—Epinastine—ABCB1—hematologic cancer	5.4e-05	0.0939	CrCbGaD
Carbamazepine—Oxcarbazepine—ALB—hematologic cancer	5.22e-05	0.0906	CrCbGaD
Carbamazepine—Phenytoin—ALB—hematologic cancer	3.45e-05	0.06	CrCbGaD
Carbamazepine—Phenytoin—ABCB1—hematologic cancer	3.3e-05	0.0573	CrCbGaD
Carbamazepine—Trimipramine—ABCB1—hematologic cancer	2.63e-05	0.0457	CrCbGaD
Carbamazepine—Promethazine—ABCB1—hematologic cancer	2.53e-05	0.044	CrCbGaD
Carbamazepine—Desipramine—ABCB1—hematologic cancer	2.3e-05	0.04	CrCbGaD
Carbamazepine—Imipramine—ABCB1—hematologic cancer	1.95e-05	0.0339	CrCbGaD
Carbamazepine—Mental disorder—Epirubicin—hematologic cancer	1.42e-05	6.08e-05	CcSEcCtD
Carbamazepine—Erythema multiforme—Doxorubicin—hematologic cancer	1.42e-05	6.07e-05	CcSEcCtD
Carbamazepine—Rash—Cisplatin—hematologic cancer	1.41e-05	6.05e-05	CcSEcCtD
Carbamazepine—Dermatitis—Cisplatin—hematologic cancer	1.41e-05	6.04e-05	CcSEcCtD
Carbamazepine—Malnutrition—Epirubicin—hematologic cancer	1.41e-05	6.04e-05	CcSEcCtD
Carbamazepine—Erythema—Epirubicin—hematologic cancer	1.41e-05	6.04e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Etoposide—hematologic cancer	1.4e-05	6.01e-05	CcSEcCtD
Carbamazepine—Anorexia—Prednisone—hematologic cancer	1.4e-05	6e-05	CcSEcCtD
Carbamazepine—Eye disorder—Doxorubicin—hematologic cancer	1.4e-05	6e-05	CcSEcCtD
Carbamazepine—Tinnitus—Doxorubicin—hematologic cancer	1.4e-05	5.98e-05	CcSEcCtD
Carbamazepine—Anaemia—Methotrexate—hematologic cancer	1.39e-05	5.96e-05	CcSEcCtD
Carbamazepine—Feeling abnormal—Betamethasone—hematologic cancer	1.39e-05	5.96e-05	CcSEcCtD
Carbamazepine—Feeling abnormal—Dexamethasone—hematologic cancer	1.39e-05	5.96e-05	CcSEcCtD
Carbamazepine—Flushing—Doxorubicin—hematologic cancer	1.39e-05	5.96e-05	CcSEcCtD
Carbamazepine—Cardiac disorder—Doxorubicin—hematologic cancer	1.39e-05	5.96e-05	CcSEcCtD
Carbamazepine—Tension—Epirubicin—hematologic cancer	1.38e-05	5.92e-05	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.38e-05	5.92e-05	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.38e-05	5.92e-05	CcSEcCtD
Carbamazepine—Dysgeusia—Epirubicin—hematologic cancer	1.38e-05	5.91e-05	CcSEcCtD
Carbamazepine—Hypersensitivity—Triamcinolone—hematologic cancer	1.37e-05	5.87e-05	CcSEcCtD
Carbamazepine—Nervousness—Epirubicin—hematologic cancer	1.37e-05	5.86e-05	CcSEcCtD
Carbamazepine—Back pain—Epirubicin—hematologic cancer	1.36e-05	5.84e-05	CcSEcCtD
Carbamazepine—Angiopathy—Doxorubicin—hematologic cancer	1.36e-05	5.82e-05	CcSEcCtD
Carbamazepine—Dizziness—Etoposide—hematologic cancer	1.36e-05	5.81e-05	CcSEcCtD
Carbamazepine—Muscle spasms—Epirubicin—hematologic cancer	1.35e-05	5.8e-05	CcSEcCtD
Carbamazepine—Immune system disorder—Doxorubicin—hematologic cancer	1.35e-05	5.8e-05	CcSEcCtD
Carbamazepine—Vertigo—Methotrexate—hematologic cancer	1.35e-05	5.8e-05	CcSEcCtD
Carbamazepine—Mediastinal disorder—Doxorubicin—hematologic cancer	1.35e-05	5.78e-05	CcSEcCtD
Carbamazepine—Leukopenia—Methotrexate—hematologic cancer	1.35e-05	5.77e-05	CcSEcCtD
Carbamazepine—Chills—Doxorubicin—hematologic cancer	1.34e-05	5.76e-05	CcSEcCtD
Carbamazepine—Urticaria—Betamethasone—hematologic cancer	1.34e-05	5.75e-05	CcSEcCtD
Carbamazepine—Urticaria—Dexamethasone—hematologic cancer	1.34e-05	5.75e-05	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.34e-05	5.74e-05	CcSEcCtD
Carbamazepine—Dizziness—Prednisolone—hematologic cancer	1.34e-05	5.73e-05	CcSEcCtD
Carbamazepine—Arrhythmia—Doxorubicin—hematologic cancer	1.34e-05	5.73e-05	CcSEcCtD
Carbamazepine—Asthenia—Triamcinolone—hematologic cancer	1.33e-05	5.72e-05	CcSEcCtD
Carbamazepine—Abdominal pain—Betamethasone—hematologic cancer	1.33e-05	5.72e-05	CcSEcCtD
Carbamazepine—Body temperature increased—Betamethasone—hematologic cancer	1.33e-05	5.72e-05	CcSEcCtD
Carbamazepine—Abdominal pain—Dexamethasone—hematologic cancer	1.33e-05	5.72e-05	CcSEcCtD
Carbamazepine—Body temperature increased—Dexamethasone—hematologic cancer	1.33e-05	5.72e-05	CcSEcCtD
Carbamazepine—Nausea—Cisplatin—hematologic cancer	1.33e-05	5.7e-05	CcSEcCtD
Carbamazepine—Insomnia—Prednisone—hematologic cancer	1.33e-05	5.7e-05	CcSEcCtD
Carbamazepine—Vision blurred—Epirubicin—hematologic cancer	1.33e-05	5.69e-05	CcSEcCtD
Carbamazepine—Alopecia—Doxorubicin—hematologic cancer	1.32e-05	5.67e-05	CcSEcCtD
Carbamazepine—Paraesthesia—Prednisone—hematologic cancer	1.32e-05	5.66e-05	CcSEcCtD
Carbamazepine—Pruritus—Triamcinolone—hematologic cancer	1.32e-05	5.64e-05	CcSEcCtD
Carbamazepine—Mental disorder—Doxorubicin—hematologic cancer	1.31e-05	5.62e-05	CcSEcCtD
Carbamazepine—Convulsion—Methotrexate—hematologic cancer	1.3e-05	5.59e-05	CcSEcCtD
Carbamazepine—Vomiting—Etoposide—hematologic cancer	1.3e-05	5.59e-05	CcSEcCtD
Carbamazepine—Erythema—Doxorubicin—hematologic cancer	1.3e-05	5.59e-05	CcSEcCtD
Carbamazepine—Malnutrition—Doxorubicin—hematologic cancer	1.3e-05	5.59e-05	CcSEcCtD
Carbamazepine—Anaemia—Epirubicin—hematologic cancer	1.3e-05	5.58e-05	CcSEcCtD
Carbamazepine—Agitation—Epirubicin—hematologic cancer	1.29e-05	5.55e-05	CcSEcCtD
Carbamazepine—Dyspepsia—Prednisone—hematologic cancer	1.29e-05	5.55e-05	CcSEcCtD
Carbamazepine—Rash—Etoposide—hematologic cancer	1.29e-05	5.54e-05	CcSEcCtD
Carbamazepine—Dermatitis—Etoposide—hematologic cancer	1.29e-05	5.54e-05	CcSEcCtD
Carbamazepine—Headache—Etoposide—hematologic cancer	1.29e-05	5.51e-05	CcSEcCtD
Carbamazepine—Arthralgia—Methotrexate—hematologic cancer	1.28e-05	5.49e-05	CcSEcCtD
Carbamazepine—Chest pain—Methotrexate—hematologic cancer	1.28e-05	5.49e-05	CcSEcCtD
Carbamazepine—Myalgia—Methotrexate—hematologic cancer	1.28e-05	5.49e-05	CcSEcCtD
Carbamazepine—Tension—Doxorubicin—hematologic cancer	1.28e-05	5.48e-05	CcSEcCtD
Carbamazepine—Decreased appetite—Prednisone—hematologic cancer	1.28e-05	5.48e-05	CcSEcCtD
Carbamazepine—Dysgeusia—Doxorubicin—hematologic cancer	1.28e-05	5.47e-05	CcSEcCtD
Carbamazepine—Rash—Prednisolone—hematologic cancer	1.28e-05	5.47e-05	CcSEcCtD
Carbamazepine—Dermatitis—Prednisolone—hematologic cancer	1.27e-05	5.46e-05	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.27e-05	5.45e-05	CcSEcCtD
Carbamazepine—Fatigue—Prednisone—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Carbamazepine—Headache—Prednisolone—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Carbamazepine—Nervousness—Doxorubicin—hematologic cancer	1.27e-05	5.43e-05	CcSEcCtD
Carbamazepine—Vertigo—Epirubicin—hematologic cancer	1.27e-05	5.42e-05	CcSEcCtD
Carbamazepine—Syncope—Epirubicin—hematologic cancer	1.26e-05	5.41e-05	CcSEcCtD
Carbamazepine—Leukopenia—Epirubicin—hematologic cancer	1.26e-05	5.4e-05	CcSEcCtD
Carbamazepine—Back pain—Doxorubicin—hematologic cancer	1.26e-05	5.4e-05	CcSEcCtD
Carbamazepine—Constipation—Prednisone—hematologic cancer	1.26e-05	5.39e-05	CcSEcCtD
Carbamazepine—Muscle spasms—Doxorubicin—hematologic cancer	1.25e-05	5.37e-05	CcSEcCtD
Carbamazepine—Confusional state—Methotrexate—hematologic cancer	1.24e-05	5.31e-05	CcSEcCtD
Carbamazepine—Loss of consciousness—Epirubicin—hematologic cancer	1.24e-05	5.31e-05	CcSEcCtD
Carbamazepine—Dizziness—Triamcinolone—hematologic cancer	1.23e-05	5.27e-05	CcSEcCtD
Carbamazepine—Anaphylactic shock—Methotrexate—hematologic cancer	1.23e-05	5.26e-05	CcSEcCtD
Carbamazepine—Vision blurred—Doxorubicin—hematologic cancer	1.23e-05	5.26e-05	CcSEcCtD
Carbamazepine—Convulsion—Epirubicin—hematologic cancer	1.22e-05	5.23e-05	CcSEcCtD
Carbamazepine—Infection—Methotrexate—hematologic cancer	1.22e-05	5.23e-05	CcSEcCtD
Carbamazepine—Nausea—Etoposide—hematologic cancer	1.22e-05	5.22e-05	CcSEcCtD
Carbamazepine—Hypertension—Epirubicin—hematologic cancer	1.22e-05	5.21e-05	CcSEcCtD
Carbamazepine—Feeling abnormal—Prednisone—hematologic cancer	1.21e-05	5.19e-05	CcSEcCtD
Carbamazepine—Asthenia—Betamethasone—hematologic cancer	1.21e-05	5.19e-05	CcSEcCtD
Carbamazepine—Asthenia—Dexamethasone—hematologic cancer	1.21e-05	5.19e-05	CcSEcCtD
Carbamazepine—Nervous system disorder—Methotrexate—hematologic cancer	1.2e-05	5.16e-05	CcSEcCtD
Carbamazepine—Anaemia—Doxorubicin—hematologic cancer	1.2e-05	5.16e-05	CcSEcCtD
Carbamazepine—Thrombocytopenia—Methotrexate—hematologic cancer	1.2e-05	5.15e-05	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Prednisone—hematologic cancer	1.2e-05	5.15e-05	CcSEcCtD
Carbamazepine—Nausea—Prednisolone—hematologic cancer	1.2e-05	5.15e-05	CcSEcCtD
Carbamazepine—Arthralgia—Epirubicin—hematologic cancer	1.2e-05	5.14e-05	CcSEcCtD
Carbamazepine—Chest pain—Epirubicin—hematologic cancer	1.2e-05	5.14e-05	CcSEcCtD
Carbamazepine—Myalgia—Epirubicin—hematologic cancer	1.2e-05	5.14e-05	CcSEcCtD
Carbamazepine—Agitation—Doxorubicin—hematologic cancer	1.2e-05	5.13e-05	CcSEcCtD
Carbamazepine—Anxiety—Epirubicin—hematologic cancer	1.2e-05	5.12e-05	CcSEcCtD
Carbamazepine—Pruritus—Dexamethasone—hematologic cancer	1.19e-05	5.12e-05	CcSEcCtD
Carbamazepine—Pruritus—Betamethasone—hematologic cancer	1.19e-05	5.12e-05	CcSEcCtD
Carbamazepine—Skin disorder—Methotrexate—hematologic cancer	1.19e-05	5.11e-05	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.19e-05	5.1e-05	CcSEcCtD
Carbamazepine—Hyperhidrosis—Methotrexate—hematologic cancer	1.19e-05	5.09e-05	CcSEcCtD
Carbamazepine—Vomiting—Triamcinolone—hematologic cancer	1.18e-05	5.07e-05	CcSEcCtD
Carbamazepine—Rash—Triamcinolone—hematologic cancer	1.17e-05	5.03e-05	CcSEcCtD
Carbamazepine—Dry mouth—Epirubicin—hematologic cancer	1.17e-05	5.03e-05	CcSEcCtD
Carbamazepine—Dermatitis—Triamcinolone—hematologic cancer	1.17e-05	5.02e-05	CcSEcCtD
Carbamazepine—Vertigo—Doxorubicin—hematologic cancer	1.17e-05	5.02e-05	CcSEcCtD
Carbamazepine—Anorexia—Methotrexate—hematologic cancer	1.17e-05	5.02e-05	CcSEcCtD
Carbamazepine—Syncope—Doxorubicin—hematologic cancer	1.17e-05	5.01e-05	CcSEcCtD
Carbamazepine—Urticaria—Prednisone—hematologic cancer	1.17e-05	5e-05	CcSEcCtD
Carbamazepine—Leukopenia—Doxorubicin—hematologic cancer	1.17e-05	5e-05	CcSEcCtD
Carbamazepine—Headache—Triamcinolone—hematologic cancer	1.17e-05	4.99e-05	CcSEcCtD
Carbamazepine—Abdominal pain—Prednisone—hematologic cancer	1.16e-05	4.98e-05	CcSEcCtD
Carbamazepine—Body temperature increased—Prednisone—hematologic cancer	1.16e-05	4.98e-05	CcSEcCtD
Carbamazepine—Confusional state—Epirubicin—hematologic cancer	1.16e-05	4.97e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Dexamethasone—hematologic cancer	1.16e-05	4.95e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Betamethasone—hematologic cancer	1.16e-05	4.95e-05	CcSEcCtD
Carbamazepine—Oedema—Epirubicin—hematologic cancer	1.15e-05	4.93e-05	CcSEcCtD
Carbamazepine—Anaphylactic shock—Epirubicin—hematologic cancer	1.15e-05	4.93e-05	CcSEcCtD
Carbamazepine—Hypotension—Methotrexate—hematologic cancer	1.15e-05	4.92e-05	CcSEcCtD
Carbamazepine—Loss of consciousness—Doxorubicin—hematologic cancer	1.15e-05	4.91e-05	CcSEcCtD
Carbamazepine—Infection—Epirubicin—hematologic cancer	1.14e-05	4.89e-05	CcSEcCtD
Carbamazepine—Shock—Epirubicin—hematologic cancer	1.13e-05	4.85e-05	CcSEcCtD
Carbamazepine—Convulsion—Doxorubicin—hematologic cancer	1.13e-05	4.84e-05	CcSEcCtD
Carbamazepine—Nervous system disorder—Epirubicin—hematologic cancer	1.13e-05	4.83e-05	CcSEcCtD
Carbamazepine—Thrombocytopenia—Epirubicin—hematologic cancer	1.13e-05	4.82e-05	CcSEcCtD
Carbamazepine—Hypertension—Doxorubicin—hematologic cancer	1.13e-05	4.82e-05	CcSEcCtD
Carbamazepine—Tachycardia—Epirubicin—hematologic cancer	1.12e-05	4.81e-05	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.12e-05	4.8e-05	CcSEcCtD
Carbamazepine—Skin disorder—Epirubicin—hematologic cancer	1.12e-05	4.79e-05	CcSEcCtD
Carbamazepine—Dizziness—Dexamethasone—hematologic cancer	1.12e-05	4.78e-05	CcSEcCtD
Carbamazepine—Dizziness—Betamethasone—hematologic cancer	1.12e-05	4.78e-05	CcSEcCtD
Carbamazepine—Hyperhidrosis—Epirubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Carbamazepine—Insomnia—Methotrexate—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Carbamazepine—Arthralgia—Doxorubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Carbamazepine—Chest pain—Doxorubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Carbamazepine—Myalgia—Doxorubicin—hematologic cancer	1.11e-05	4.76e-05	CcSEcCtD
Carbamazepine—Anxiety—Doxorubicin—hematologic cancer	1.11e-05	4.74e-05	CcSEcCtD
Carbamazepine—Nausea—Triamcinolone—hematologic cancer	1.11e-05	4.74e-05	CcSEcCtD
Carbamazepine—Paraesthesia—Methotrexate—hematologic cancer	1.1e-05	4.73e-05	CcSEcCtD
Carbamazepine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.1e-05	4.72e-05	CcSEcCtD
Carbamazepine—Anorexia—Epirubicin—hematologic cancer	1.1e-05	4.7e-05	CcSEcCtD
Carbamazepine—Dyspnoea—Methotrexate—hematologic cancer	1.1e-05	4.69e-05	CcSEcCtD
Carbamazepine—Somnolence—Methotrexate—hematologic cancer	1.09e-05	4.68e-05	CcSEcCtD
Carbamazepine—Dry mouth—Doxorubicin—hematologic cancer	1.09e-05	4.65e-05	CcSEcCtD
Carbamazepine—Hypersensitivity—Prednisone—hematologic cancer	1.08e-05	4.64e-05	CcSEcCtD
Carbamazepine—Dyspepsia—Methotrexate—hematologic cancer	1.08e-05	4.63e-05	CcSEcCtD
Carbamazepine—Hypotension—Epirubicin—hematologic cancer	1.07e-05	4.6e-05	CcSEcCtD
Carbamazepine—Vomiting—Dexamethasone—hematologic cancer	1.07e-05	4.6e-05	CcSEcCtD
Carbamazepine—Vomiting—Betamethasone—hematologic cancer	1.07e-05	4.6e-05	CcSEcCtD
Carbamazepine—Confusional state—Doxorubicin—hematologic cancer	1.07e-05	4.6e-05	CcSEcCtD
Carbamazepine—Decreased appetite—Methotrexate—hematologic cancer	1.07e-05	4.58e-05	CcSEcCtD
Carbamazepine—Rash—Betamethasone—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Carbamazepine—Rash—Dexamethasone—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Carbamazepine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Carbamazepine—Oedema—Doxorubicin—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Carbamazepine—Dermatitis—Betamethasone—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Carbamazepine—Dermatitis—Dexamethasone—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.06e-05	4.55e-05	CcSEcCtD
Carbamazepine—Fatigue—Methotrexate—hematologic cancer	1.06e-05	4.54e-05	CcSEcCtD
Carbamazepine—Headache—Dexamethasone—hematologic cancer	1.06e-05	4.53e-05	CcSEcCtD
Carbamazepine—Headache—Betamethasone—hematologic cancer	1.06e-05	4.53e-05	CcSEcCtD
Carbamazepine—Infection—Doxorubicin—hematologic cancer	1.06e-05	4.53e-05	CcSEcCtD
Carbamazepine—Asthenia—Prednisone—hematologic cancer	1.05e-05	4.52e-05	CcSEcCtD
Carbamazepine—Pain—Methotrexate—hematologic cancer	1.05e-05	4.5e-05	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.05e-05	4.49e-05	CcSEcCtD
Carbamazepine—Shock—Doxorubicin—hematologic cancer	1.05e-05	4.49e-05	CcSEcCtD
Carbamazepine—Nervous system disorder—Doxorubicin—hematologic cancer	1.04e-05	4.47e-05	CcSEcCtD
Carbamazepine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.04e-05	4.46e-05	CcSEcCtD
Carbamazepine—Pruritus—Prednisone—hematologic cancer	1.04e-05	4.46e-05	CcSEcCtD
Carbamazepine—Insomnia—Epirubicin—hematologic cancer	1.04e-05	4.46e-05	CcSEcCtD
Carbamazepine—Tachycardia—Doxorubicin—hematologic cancer	1.04e-05	4.45e-05	CcSEcCtD
Carbamazepine—Skin disorder—Doxorubicin—hematologic cancer	1.03e-05	4.43e-05	CcSEcCtD
Carbamazepine—Paraesthesia—Epirubicin—hematologic cancer	1.03e-05	4.42e-05	CcSEcCtD
Carbamazepine—Hyperhidrosis—Doxorubicin—hematologic cancer	1.03e-05	4.41e-05	CcSEcCtD
Carbamazepine—Dyspnoea—Epirubicin—hematologic cancer	1.03e-05	4.39e-05	CcSEcCtD
Carbamazepine—Somnolence—Epirubicin—hematologic cancer	1.02e-05	4.38e-05	CcSEcCtD
Carbamazepine—Anorexia—Doxorubicin—hematologic cancer	1.01e-05	4.35e-05	CcSEcCtD
Carbamazepine—Feeling abnormal—Methotrexate—hematologic cancer	1.01e-05	4.34e-05	CcSEcCtD
Carbamazepine—Dyspepsia—Epirubicin—hematologic cancer	1.01e-05	4.34e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Prednisone—hematologic cancer	1.01e-05	4.31e-05	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Methotrexate—hematologic cancer	1e-05	4.31e-05	CcSEcCtD
Carbamazepine—Nausea—Dexamethasone—hematologic cancer	1e-05	4.3e-05	CcSEcCtD
Carbamazepine—Nausea—Betamethasone—hematologic cancer	1e-05	4.3e-05	CcSEcCtD
Carbamazepine—Decreased appetite—Epirubicin—hematologic cancer	1e-05	4.28e-05	CcSEcCtD
Carbamazepine—Hypotension—Doxorubicin—hematologic cancer	9.94e-06	4.26e-05	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.93e-06	4.25e-05	CcSEcCtD
Carbamazepine—Fatigue—Epirubicin—hematologic cancer	9.91e-06	4.25e-05	CcSEcCtD
Carbamazepine—Pain—Epirubicin—hematologic cancer	9.83e-06	4.21e-05	CcSEcCtD
Carbamazepine—Constipation—Epirubicin—hematologic cancer	9.83e-06	4.21e-05	CcSEcCtD
Carbamazepine—Urticaria—Methotrexate—hematologic cancer	9.76e-06	4.18e-05	CcSEcCtD
Carbamazepine—Dizziness—Prednisone—hematologic cancer	9.72e-06	4.17e-05	CcSEcCtD
Carbamazepine—Abdominal pain—Methotrexate—hematologic cancer	9.71e-06	4.16e-05	CcSEcCtD
Carbamazepine—Body temperature increased—Methotrexate—hematologic cancer	9.71e-06	4.16e-05	CcSEcCtD
Carbamazepine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	9.69e-06	4.15e-05	CcSEcCtD
Carbamazepine—Insomnia—Doxorubicin—hematologic cancer	9.62e-06	4.12e-05	CcSEcCtD
Carbamazepine—Paraesthesia—Doxorubicin—hematologic cancer	9.55e-06	4.09e-05	CcSEcCtD
Carbamazepine—Dyspnoea—Doxorubicin—hematologic cancer	9.49e-06	4.06e-05	CcSEcCtD
Carbamazepine—Feeling abnormal—Epirubicin—hematologic cancer	9.48e-06	4.06e-05	CcSEcCtD
Carbamazepine—Somnolence—Doxorubicin—hematologic cancer	9.46e-06	4.05e-05	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Epirubicin—hematologic cancer	9.4e-06	4.03e-05	CcSEcCtD
Carbamazepine—Dyspepsia—Doxorubicin—hematologic cancer	9.37e-06	4.01e-05	CcSEcCtD
Carbamazepine—Vomiting—Prednisone—hematologic cancer	9.35e-06	4.01e-05	CcSEcCtD
Carbamazepine—Rash—Prednisone—hematologic cancer	9.27e-06	3.97e-05	CcSEcCtD
Carbamazepine—Dermatitis—Prednisone—hematologic cancer	9.26e-06	3.97e-05	CcSEcCtD
Carbamazepine—Decreased appetite—Doxorubicin—hematologic cancer	9.25e-06	3.96e-05	CcSEcCtD
Carbamazepine—Headache—Prednisone—hematologic cancer	9.21e-06	3.95e-05	CcSEcCtD
Carbamazepine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.19e-06	3.94e-05	CcSEcCtD
Carbamazepine—Fatigue—Doxorubicin—hematologic cancer	9.17e-06	3.93e-05	CcSEcCtD
Carbamazepine—Urticaria—Epirubicin—hematologic cancer	9.13e-06	3.91e-05	CcSEcCtD
Carbamazepine—Pain—Doxorubicin—hematologic cancer	9.1e-06	3.9e-05	CcSEcCtD
Carbamazepine—Constipation—Doxorubicin—hematologic cancer	9.1e-06	3.9e-05	CcSEcCtD
Carbamazepine—Abdominal pain—Epirubicin—hematologic cancer	9.09e-06	3.89e-05	CcSEcCtD
Carbamazepine—Body temperature increased—Epirubicin—hematologic cancer	9.09e-06	3.89e-05	CcSEcCtD
Carbamazepine—Hypersensitivity—Methotrexate—hematologic cancer	9.05e-06	3.88e-05	CcSEcCtD
Carbamazepine—Asthenia—Methotrexate—hematologic cancer	8.82e-06	3.78e-05	CcSEcCtD
Carbamazepine—Feeling abnormal—Doxorubicin—hematologic cancer	8.77e-06	3.76e-05	CcSEcCtD
Carbamazepine—Nausea—Prednisone—hematologic cancer	8.73e-06	3.74e-05	CcSEcCtD
Carbamazepine—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.7e-06	3.73e-05	CcSEcCtD
Carbamazepine—Pruritus—Methotrexate—hematologic cancer	8.69e-06	3.72e-05	CcSEcCtD
Carbamazepine—Hypersensitivity—Epirubicin—hematologic cancer	8.47e-06	3.63e-05	CcSEcCtD
Carbamazepine—Urticaria—Doxorubicin—hematologic cancer	8.45e-06	3.62e-05	CcSEcCtD
Carbamazepine—Body temperature increased—Doxorubicin—hematologic cancer	8.41e-06	3.6e-05	CcSEcCtD
Carbamazepine—Abdominal pain—Doxorubicin—hematologic cancer	8.41e-06	3.6e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Methotrexate—hematologic cancer	8.41e-06	3.6e-05	CcSEcCtD
Carbamazepine—Asthenia—Epirubicin—hematologic cancer	8.25e-06	3.54e-05	CcSEcCtD
Carbamazepine—Pruritus—Epirubicin—hematologic cancer	8.14e-06	3.49e-05	CcSEcCtD
Carbamazepine—Dizziness—Methotrexate—hematologic cancer	8.13e-06	3.48e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Epirubicin—hematologic cancer	7.87e-06	3.37e-05	CcSEcCtD
Carbamazepine—Hypersensitivity—Doxorubicin—hematologic cancer	7.84e-06	3.36e-05	CcSEcCtD
Carbamazepine—Vomiting—Methotrexate—hematologic cancer	7.81e-06	3.35e-05	CcSEcCtD
Carbamazepine—Rash—Methotrexate—hematologic cancer	7.75e-06	3.32e-05	CcSEcCtD
Carbamazepine—Dermatitis—Methotrexate—hematologic cancer	7.74e-06	3.32e-05	CcSEcCtD
Carbamazepine—Headache—Methotrexate—hematologic cancer	7.7e-06	3.3e-05	CcSEcCtD
Carbamazepine—Asthenia—Doxorubicin—hematologic cancer	7.63e-06	3.27e-05	CcSEcCtD
Carbamazepine—Dizziness—Epirubicin—hematologic cancer	7.6e-06	3.26e-05	CcSEcCtD
Carbamazepine—Pruritus—Doxorubicin—hematologic cancer	7.53e-06	3.23e-05	CcSEcCtD
Carbamazepine—Vomiting—Epirubicin—hematologic cancer	7.31e-06	3.13e-05	CcSEcCtD
Carbamazepine—Nausea—Methotrexate—hematologic cancer	7.3e-06	3.13e-05	CcSEcCtD
Carbamazepine—Diarrhoea—Doxorubicin—hematologic cancer	7.28e-06	3.12e-05	CcSEcCtD
Carbamazepine—Rash—Epirubicin—hematologic cancer	7.25e-06	3.11e-05	CcSEcCtD
Carbamazepine—Dermatitis—Epirubicin—hematologic cancer	7.24e-06	3.1e-05	CcSEcCtD
Carbamazepine—Headache—Epirubicin—hematologic cancer	7.2e-06	3.09e-05	CcSEcCtD
Carbamazepine—Dizziness—Doxorubicin—hematologic cancer	7.04e-06	3.01e-05	CcSEcCtD
Carbamazepine—Nausea—Epirubicin—hematologic cancer	6.83e-06	2.93e-05	CcSEcCtD
Carbamazepine—Vomiting—Doxorubicin—hematologic cancer	6.76e-06	2.9e-05	CcSEcCtD
Carbamazepine—Rash—Doxorubicin—hematologic cancer	6.71e-06	2.87e-05	CcSEcCtD
Carbamazepine—Dermatitis—Doxorubicin—hematologic cancer	6.7e-06	2.87e-05	CcSEcCtD
Carbamazepine—Headache—Doxorubicin—hematologic cancer	6.67e-06	2.86e-05	CcSEcCtD
Carbamazepine—Nausea—Doxorubicin—hematologic cancer	6.32e-06	2.71e-05	CcSEcCtD
Carbamazepine—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.05e-06	5.67e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—MTHFR—hematologic cancer	4.04e-06	5.65e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ENO2—hematologic cancer	4.04e-06	5.65e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTO1—hematologic cancer	4.03e-06	5.64e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCC3—hematologic cancer	4.03e-06	5.64e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—TXN—hematologic cancer	4.03e-06	5.64e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTT1—hematologic cancer	4.01e-06	5.61e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.96e-06	5.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ADCY7—hematologic cancer	3.95e-06	5.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NCOA3—hematologic cancer	3.95e-06	5.53e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.95e-06	5.53e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SPHK1—hematologic cancer	3.94e-06	5.52e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—FHL2—hematologic cancer	3.94e-06	5.51e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NUP214—hematologic cancer	3.93e-06	5.49e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—SDC1—hematologic cancer	3.92e-06	5.49e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTT1—hematologic cancer	3.92e-06	5.48e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.88e-06	5.44e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AGRN—hematologic cancer	3.86e-06	5.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCG2—hematologic cancer	3.85e-06	5.38e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MTR—hematologic cancer	3.85e-06	5.38e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—SDC1—hematologic cancer	3.83e-06	5.36e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CB—hematologic cancer	3.81e-06	5.33e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.8e-06	5.32e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—UGT1A1—hematologic cancer	3.79e-06	5.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ENO2—hematologic cancer	3.77e-06	5.28e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.75e-06	5.24e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CD44—hematologic cancer	3.74e-06	5.23e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NQO1—hematologic cancer	3.74e-06	5.23e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.7e-06	5.17e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.69e-06	5.16e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.69e-06	5.16e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.68e-06	5.15e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.67e-06	5.13e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HMMR—hematologic cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—IDH2—hematologic cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.66e-06	5.12e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.6e-06	5.04e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.6e-06	5.03e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.59e-06	5.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—SDC1—hematologic cancer	3.58e-06	5e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.54e-06	4.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CYCS—hematologic cancer	3.53e-06	4.95e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.51e-06	4.91e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.48e-06	4.87e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NUP98—hematologic cancer	3.48e-06	4.87e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.44e-06	4.81e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.43e-06	4.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.42e-06	4.78e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.4e-06	4.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3.4e-06	4.75e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.38e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.38e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.38e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.38e-06	4.73e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.37e-06	4.72e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NUP214—hematologic cancer	3.35e-06	4.69e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ACP5—hematologic cancer	3.35e-06	4.68e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CA9—hematologic cancer	3.35e-06	4.68e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NQO1—hematologic cancer	3.33e-06	4.67e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CD44—hematologic cancer	3.33e-06	4.67e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.32e-06	4.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.31e-06	4.62e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.31e-06	4.62e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.3e-06	4.62e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PTEN—hematologic cancer	3.29e-06	4.6e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.29e-06	4.6e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MTR—hematologic cancer	3.29e-06	4.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.26e-06	4.57e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NQO1—hematologic cancer	3.25e-06	4.55e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CD44—hematologic cancer	3.25e-06	4.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.22e-06	4.51e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ENO2—hematologic cancer	3.22e-06	4.51e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.16e-06	4.42e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.15e-06	4.41e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.15e-06	4.4e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.15e-06	4.4e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—EP300—hematologic cancer	3.14e-06	4.39e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.13e-06	4.39e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.13e-06	4.37e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.12e-06	4.36e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.11e-06	4.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.11e-06	4.35e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—TXN—hematologic cancer	3.11e-06	4.35e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CYCS—hematologic cancer	3.08e-06	4.31e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.08e-06	4.31e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.06e-06	4.28e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—SDC1—hematologic cancer	3.06e-06	4.28e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.04e-06	4.26e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CD44—hematologic cancer	3.04e-06	4.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NQO1—hematologic cancer	3.04e-06	4.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.01e-06	4.22e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—MTHFR—hematologic cancer	2.99e-06	4.18e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.98e-06	4.18e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.98e-06	4.17e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ABCB1—hematologic cancer	2.95e-06	4.13e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—ALB—hematologic cancer	2.95e-06	4.12e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.93e-06	4.09e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.92e-06	4.09e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.92e-06	4.08e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.88e-06	4.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CYCS—hematologic cancer	2.88e-06	4.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—NCOR1—hematologic cancer	2.86e-06	4.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—GSTM1—hematologic cancer	2.86e-06	4.01e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	2.86e-06	4e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.85e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.85e-06	3.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.82e-06	3.95e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.82e-06	3.94e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.78e-06	3.89e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.77e-06	3.88e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.76e-06	3.86e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTP1—hematologic cancer	2.71e-06	3.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.69e-06	3.76e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NUP98—hematologic cancer	2.69e-06	3.76e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.63e-06	3.68e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.61e-06	3.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.61e-06	3.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.6e-06	3.64e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NQO1—hematologic cancer	2.6e-06	3.63e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CD44—hematologic cancer	2.6e-06	3.63e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NUP214—hematologic cancer	2.59e-06	3.62e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.57e-06	3.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.56e-06	3.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.56e-06	3.58e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.54e-06	3.56e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.54e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTR—hematologic cancer	2.54e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.54e-06	3.55e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.53e-06	3.54e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.51e-06	3.51e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—GSTM1—hematologic cancer	2.49e-06	3.49e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—NCOR1—hematologic cancer	2.49e-06	3.49e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ENO2—hematologic cancer	2.49e-06	3.48e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CYCS—hematologic cancer	2.46e-06	3.44e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.45e-06	3.43e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.45e-06	3.43e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.44e-06	3.42e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.41e-06	3.38e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.4e-06	3.36e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.36e-06	3.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.33e-06	3.26e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—PIK3CA—hematologic cancer	2.32e-06	3.25e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.28e-06	3.18e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.26e-06	3.16e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PTEN—hematologic cancer	2.25e-06	3.15e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.23e-06	3.12e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.21e-06	3.09e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—MTHFR—hematologic cancer	2.2e-06	3.08e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.2e-06	3.08e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—ALB—hematologic cancer	2.18e-06	3.05e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.17e-06	3.03e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.16e-06	3.02e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—EP300—hematologic cancer	2.14e-06	3e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—ALB—hematologic cancer	2.13e-06	2.98e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.13e-06	2.97e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.1e-06	2.93e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.08e-06	2.92e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.06e-06	2.88e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.05e-06	2.87e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.04e-06	2.85e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NQO1—hematologic cancer	2e-06	2.81e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CD44—hematologic cancer	2e-06	2.81e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—GSTM1—hematologic cancer	1.99e-06	2.79e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—NCOR1—hematologic cancer	1.99e-06	2.79e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.99e-06	2.78e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—CREBBP—hematologic cancer	1.97e-06	2.76e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	1.92e-06	2.69e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	1.9e-06	2.66e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CYCS—hematologic cancer	1.9e-06	2.65e-05	CbGpPWpGaD
Carbamazepine—UGT2B7—Metabolism—AKT1—hematologic cancer	1.9e-06	2.65e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.88e-06	2.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.88e-06	2.63e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CD—hematologic cancer	1.87e-06	2.61e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.85e-06	2.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—ALB—hematologic cancer	1.84e-06	2.58e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.81e-06	2.54e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.76e-06	2.47e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.76e-06	2.46e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.76e-06	2.46e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.73e-06	2.42e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—CREBBP—hematologic cancer	1.72e-06	2.4e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.67e-06	2.34e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.67e-06	2.33e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PTEN—hematologic cancer	1.66e-06	2.33e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—ALB—hematologic cancer	1.65e-06	2.3e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.63e-06	2.28e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.63e-06	2.28e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PTEN—hematologic cancer	1.62e-06	2.27e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—ALB—hematologic cancer	1.61e-06	2.25e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.6e-06	2.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.59e-06	2.22e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—EP300—hematologic cancer	1.59e-06	2.22e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.58e-06	2.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.58e-06	2.2e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.55e-06	2.17e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—EP300—hematologic cancer	1.55e-06	2.17e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.54e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.54e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.54e-06	2.15e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.52e-06	2.13e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—ALB—hematologic cancer	1.5e-06	2.1e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.48e-06	2.07e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.45e-06	2.03e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.44e-06	2.01e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.42e-06	1.99e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PTEN—hematologic cancer	1.41e-06	1.97e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.37e-06	1.92e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.36e-06	1.9e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—EP300—hematologic cancer	1.34e-06	1.88e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.33e-06	1.85e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.3e-06	1.82e-05	CbGpPWpGaD
Carbamazepine—CYP3A7—Metabolism—AKT1—hematologic cancer	1.3e-06	1.81e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—ALB—hematologic cancer	1.28e-06	1.8e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.26e-06	1.76e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.23e-06	1.72e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PTEN—hematologic cancer	1.23e-06	1.72e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—EP300—hematologic cancer	1.2e-06	1.68e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.17e-06	1.64e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—EP300—hematologic cancer	1.17e-06	1.64e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.15e-06	1.6e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PTEN—hematologic cancer	1.15e-06	1.6e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.14e-06	1.6e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.13e-06	1.59e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—EP300—hematologic cancer	1.09e-06	1.53e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.06e-06	1.48e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1e-06	1.4e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—PIK3CA—hematologic cancer	9.93e-07	1.39e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—ALB—hematologic cancer	9.9e-07	1.39e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PTEN—hematologic cancer	9.79e-07	1.37e-05	CbGpPWpGaD
Carbamazepine—CYP2B6—Metabolism—AKT1—hematologic cancer	9.58e-07	1.34e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	9.47e-07	1.33e-05	CbGpPWpGaD
Carbamazepine—CYP3A5—Metabolism—AKT1—hematologic cancer	9.36e-07	1.31e-05	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—EP300—hematologic cancer	9.34e-07	1.31e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	8.86e-07	1.24e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	8.74e-07	1.22e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—PIK3CA—hematologic cancer	8.65e-07	1.21e-05	CbGpPWpGaD
Carbamazepine—CYP2C8—Metabolism—AKT1—hematologic cancer	8.11e-07	1.14e-05	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.08e-07	1.13e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PTEN—hematologic cancer	7.55e-07	1.06e-05	CbGpPWpGaD
Carbamazepine—CYP2C19—Metabolism—AKT1—hematologic cancer	7.24e-07	1.01e-05	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—EP300—hematologic cancer	7.2e-07	1.01e-05	CbGpPWpGaD
Carbamazepine—ABCB1—Metabolism—AKT1—hematologic cancer	7.07e-07	9.89e-06	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—PIK3CA—hematologic cancer	6.91e-07	9.66e-06	CbGpPWpGaD
Carbamazepine—CYP2C9—Metabolism—AKT1—hematologic cancer	6.6e-07	9.24e-06	CbGpPWpGaD
Carbamazepine—CYP1A2—Metabolism—AKT1—hematologic cancer	5.64e-07	7.89e-06	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.33e-07	7.46e-06	CbGpPWpGaD
Carbamazepine—CYP3A4—Metabolism—AKT1—hematologic cancer	4.35e-07	6.09e-06	CbGpPWpGaD
